medigraphic.com
ISSN 2500-7106 (Digital)
ISSN 0123-2576 (Impreso)
Medicina & Laboratorio

2009, Número 03-04

<< Anterior Siguiente >>

Medicina & Laboratorio 2009; 15 (03-04)


Influenza A

Toro MAI, Aguirre MC

Idioma: Español
Referencias bibliográficas: 91
Paginas: 111-144
Archivo PDF: 1135.74 Kb.


RESUMEN

La influenza es una enfermedad viral aguda que afecta una gran parte de lapoblación mundial cada año. Es producida por los virus de la influenza, los cuales pertenecen a la familia Orthomyxoviridae. Se conocen tres tipos: A, B y C; los virus tipo A afectan una gran variedad de especies animales, incluyendo la humana, en tanto que los tipos B y C usualmente se limitan al hombre, aunque se han aislado de focas y cerdos, respectivamente. Los virus de la influenza tienen la capacidad de producir epidemias y pandemias, debido a que constantemente se están generando nuevas cepas que logran evadir cualquier respuesta inmune previa en los hospederos. Su genoma, dividido en ocho segmentos, le permite intercambiar material genético con virus de otras especies que estén infectando una misma célula, facilitándose así la transmisión a otros hospederos. Actualmente se está presentando una amplia epidemia, causada por un virus nuevo de origen porcino, denominado A(H1N1), la cual tiene a todos los países en alerta máxima por temor a una nueva pandemia. Es necesario que los gobiernos nacionales ejerzan medidas de control eficaces para evitar una mayor diseminación de este virus y disminuir sus consecuencias nefastas


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Reid AH, Taubenberger JK. The origin of the 1918 pandemic influenza virus: a continuing enigma. J Gen Virol 2003; 84: 2285-2292.

  2. Potter CW. A history of influenza. J Appl Microbiol 2001; 91: 572-579.

  3. Osterhaus AD, Rimmelzwaan GF, Martina BE, Bestebroer TM, Fouchier RA. Influenza B virus in seals. Science 2000; 288: 1051-1053.

  4. Gouarin S, Vabret A, Dina J, Petitjean J, Brouard J, Cuvillon-Nimal D, et al. Study of influenza C virus infection in France. J Med Virol 2008; 80: 1441-1446.

  5. Kimura H, Abiko C, Peng G, Muraki Y, Sugawara K, Hongo S, et al. Interspecies transmission of influenza C virus between humans and pigs. Virus Res 1997; 48: 71-79.

  6. Fouchier RA, Munster V, Wallensten A, Bestebroer TM, Herfst S, Smith D, et al. Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. J Virol 2005; 79: 2814-2822.

  7. Webster RG, Bean WJ, Gorman OT, Chambers TM, Kawaoka Y. Evolution and ecology of influenza A viruses. Microbiol Rev 1992; 56: 152-179.

  8. Compans RW, Meier-Ewert H, Palese P. Assembly of lipid-containing viruses. J Supramol Struct 1974; 2: 496-511.

  9. Richardson JC, Akkina RK. NS2 protein of influenza virus is found in purified virus and phosphorylated in infected cells. Arch Virol 1991; 116: 69-80.

  10. Klenk HD, Rott R, Orlich M, Blodorn J. Activation of influenza A viruses by trypsin treatment. Virology 1975; 68: 426-439.

  11. Connor RJ, Kawaoka Y, Webster RG, Paulson JC. Receptor specificity in human, avian, and equine H2 and H3 influenza virus isolates. Virology 1994; 205: 17-23.

  12. Couceiro JN, Paulson JC, Baum LG. Influenza virus strains selectively recognize sialyloligosaccharides on human respiratory epithelium; the role of the host cell in selection of hemagglutinin receptor specificity. Virus Res 1993; 29: 155-165.

  13. Ito T, Couceiro JN, Kelm S, Baum LG, Krauss S, Castrucci MR, et al. Molecular basis for the generation in pigs of influenza A viruses with pandemic potential. J Virol 1998; 72: 7367-7373.

  14. Martin K, Helenius A. Transport of incoming influenza virus nucleocapsids into the nucleus. J Virol 1991; 65: 232-244.

  15. Sieczkarski SB, Whittaker GR. Viral entry. Curr Top Microbiol Immunol 2005; 285: 1-23.

  16. Stegmann T, Morselt HW, Scholma J, Wilschut J. Fusion of influenza virus in an intracellular acidic compartment measured by fluorescence dequenching. Biochim Biophys Acta 1987; 904: 165- 170.

  17. Fodor E, Brownlee G. Influenza virus replication. In: Potter CW, ed. Influenza. Amsterdam; Elsevier. 2002: 1-29.

  18. Neumann G, Brownlee GG, Fodor E, Kawaoka Y. Orthomyxovirus replication, transcription, and polyadenylation. Curr Top Microbiol Immunol 2004; 283: 121-143.

  19. Schmitt AP, Lamb RA. Influenza virus assembly and budding at the viral budozone. Adv Virus Res 2005; 64: 383-416.

  20. Nayak DP, Hui EK, Barman S. Assembly and budding of influenza virus. Virus Res 2004; 106: 147-165.

  21. Steinhauer DA, Skehel JJ. Genetics of influenza viruses. Annu Rev Genet 2002; 36: 305-332.

  22. Aguirre-Muñoz CA, Arango-Restrepo AE. Influenza aviar: estado actual. Medicina & Laboratorio 2006; 12: 411-437.

  23. Update: novel influenza A (H1N1) virus infections- worldwide, May 6, 2009. MMWR Morb Mortal Wkly Rep 2009; 58: 453-458.

  24. Kawaoka Y, Krauss S, Webster RG. Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics. J Virol 1989; 63: 4603-4608.

  25. Scholtissek C, Rohde W, Von Hoyningen V, Rott R. On the origin of the human influenza virus subtypes H2N2 and H3N2. Virology 1978; 87: 13- 20.

  26. Easterday BC. Animal influenza. In: Kilbourne ED, ed. Influenza viruses and influeza. New York; Academic Press. 1975: 449.

  27. Ludwig S, Stitz L, Planz O, Van H, Fitch WM, Scholtissek C. European swine virus as a possible source for the next influenza pandemic? Virology 1995; 212: 555-561.

  28. Belshe RB. The origins of pandemic influenza-- lessons from the 1918 virus. N Engl J Med 2005; 353: 2209-2211.

  29. Simonsen L. The global impact of influenza on morbidity and mortality. Vaccine 1999; 17 Suppl 1: S3-10.

  30. Simonsen L, Clarke MJ, Williamson GD, Stroup DF, Arden NH, Schonberger LB. The impact of influenza epidemics on mortality: introducing a severity index. Am J Public Health 1997; 87: 1944-1950.

  31. Pandemic Flu. http://www.pandemicflu.gov/index. html.

  32. Claas EC, Osterhaus AD, van Beek R, De Jong JC, Rimmelzwaan GF, Senne DA, et al. Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet 1998; 351: 472-477.

  33. Subbarao K, Klimov A, Katz J, Regnery H, Lim W, Hall H, et al. Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science 1998; 279: 393- 396.

  34. Tran TH, Nguyen TL, Nguyen TD, Luong TS, Pham PM, Nguyen VC, et al. Avian influenza A (H5N1) in 10 patients in Vietnam. N Engl J Med 2004; 350: 1179-1188.

  35. Ungchusak K, Auewarakul P, Dowell SF, Kitphati R, Auwanit W, Puthavathana P, et al. Probable person-to-person transmission of avian influenza A (H5N1). N Engl J Med 2005; 352: 333-340.

  36. WHO. Avian influenza. http://www.who.int/csr/ disease/avian_influenza/en/index.html.

  37. WHO. Influenza A(H1N1). http://www.who.int/ csr/disease/swineflu/en/index.html.

  38. Monto AS. Epidemiology of influenza. Vaccine 2008; 26 Suppl 4: D45-48.

  39. Glezen WP. Serious morbidity and mortality associated with influenza epidemics. Epidemiol Rev 1982; 4: 25-44.

  40. Barker WH, Mullooly JP. Impact of epidemic type A influenza in a defined adult population. Am J Epidemiol 1980; 112: 798-811.

  41. Sprenger MJ, Mulder PG, Beyer WE, Van Strik R, Masurel N. Impact of influenza on mortality in relation to age and underlying disease, 1967-1989. Int J Epidemiol 1993; 22: 334-340.

  42. Jordan WS, Jr., Badger GF, Dingle JH. A study of illness in a group of Cleveland families. XVI. The epidemiology of influenza, 1948-1953. Am J Hyg 1958; 68: 169-189.

  43. Alford RH, Kasel JA, Gerone PJ, Knight V. Human influenza resulting from aerosol inhalation. Proc Soc Exp Biol Med 1966; 122: 800-804.

  44. Easterday BC, Hinshaw VS, Halvorson DA. Influenza. In: Calnek BW, Barnes HJ, Beard CW, McDougald LR, Saif YM, eds. Diseases of poultry. Ames; Iowa State University Press. 1997: 583- 605.

  45. Webster RG, Kawaoka Y. Avian influenza. Crit Rev Poult Biol 1988; 1: 211–246.

  46. Kida H, Yanagawa R, Matsuoka Y. Duck influenza lacking evidence of disease signs and immune response. Infect Immun 1980; 30: 547-553.

  47. Webster RG, Yakhno M, Hinshaw VS, Bean WJ, Murti KG. Intestinal influenza: replication and characterization of influenza viruses in ducks. Virology 1978; 84: 268-278.

  48. Hinshaw VS, Webster RG, Turner B. Water-bone transmission of influenza A viruses? Intervirology 1979; 11: 66-68.

  49. Webster RG, Hinshaw VS, Bean WJ, Jr., Turner B, Shortridge KF. Influenza viruses from avian and porcine sources and their possible role in the origin of human pandemic strains. Dev Biol Stand 1977; 39: 461-468.

  50. Ito T, Suzuki Y, Suzuki T, Takada A, Horimoto T, Wells K, et al. Recognition of N-glycolylneuraminic acid linked to galactose by the alpha2,3 linkage is associated with intestinal replication of influenza A virus in ducks. J Virol 2000; 74: 9300- 9305.

  51. Alexander DJ. A review of avian influenza in different bird species. Vet Microbiol 2000; 74: 3-13.

  52. Kida H, Ito T, Yasuda J, Shimizu Y, Itakura C, Shortridge KF, et al. Potential for transmission of avian influenza viruses to pigs. J Gen Virol 1994; 75 ( Pt 9): 2183-2188.

  53. Claas EC, Kawaoka Y, de Jong JC, Masurel N, Webster RG. Infection of children with avian-human reassortant influenza virus from pigs in Europe. Virology 1994; 204: 453-457.

  54. Hinshaw VS, Bean WJ, Jr., Webster RG, Easterday BC. The prevalence of influenza viruses in swine and the antigenic and genetic relatedness of influenza viruses from man and swine. Virology 1978; 84: 51-62.

  55. Scholtissek C, Burger H, Kistner O, Shortridge KF. The nucleoprotein as a possible major factor in determining host specificity of influenza H3N2 viruses. Virology 1985; 147: 287-294.

  56. Hers JF. Broad aspects of the pathology and pathogenesis of human influenza. Am Rev Respir Dis 1961 ;83: 84–97.

  57. Walsh JJ, Dietlein LF, Low FN, Burch GE, Mogabgab WJ. Bronchotracheal response in human influenza. Type A, Asian strain, as studied by light and electron microscopic examination of bronchoscopic biopsies. Arch Intern Med 1961; 108: 376-388.

  58. Hinshaw VS, Olsen CW, Dybdahl-Sissoko N, Evans D. Apoptosis: a mechanism of cell killing by influenza A and B viruses. J Virol 1994; 68: 3667- 3673.

  59. Douglas RG. Influenza in man. In: Kilbourbe ED, ed. Influenza virus and influenza. New York; Academic Press. 1975: 397-446.

  60. Eccles R. Understanding the symptoms of the common cold and influenza. Lancet Infect Dis 2005; 5: 718-725.

  61. Paisley JW, Bruhn FW, Lauer BA, McIntosh K. Type A2 influenza viral infections in children. Am J Dis Child 1978; 132: 34-36.

  62. Price DA, Postlethwaite RJ, Longson M. Influenzavirus A2 infections presenting with febril convulsions and gastrointestinal symptoms in young children. Clin Pediatr (Phila) 1976; 15: 361-367.

  63. Hien TT, de Jong M, Farrar J. Avian influenza--a challenge to global health care structures. N Engl J Med 2004; 351: 2363-2365.

  64. Beigel JH, Farrar J, Han AM, Hayden FG, Hyer R, de Jong MD, et al. Avian influenza A (H5N1) infection in humans. N Engl J Med 2005; 353: 1374-1385. 131 Medicina & Laboratorio, Volumen 15, Números 3-4, 2009 Toro-Montoya AI, Aguirre-Muñoz CA. Medicina & Laboratorio: Programa de Educación Médica Contínua Certificada Universidad de Antioquia, Edimeco

  65. Schwarzmann SW, Adler JL, Sullivan RJ, Jr., Marine WM. Bacterial pneumonia during the Hong Kong influenza epidemic of 1968-1969. Arch Intern Med 1971; 127: 1037-1041.

  66. Robertson L, Caley JP, Moore J. Importance of Staphylococcus aureus in pneumonia in the 1957 epidemic of influenza A. Lancet 1958; 2: 233- 236.

  67. Melbye H, Berdal BP, Straume B, Russell H, Vorland L, Thacker WL. Pneumonia--a clinical orradiographic diagnosis? Etiology and clinical features of lower respiratory tract infection in adults in general practice. Scand J Infect Dis 1992; 24: 647-655.

  68. Dwyer DE, Smith DW, Catton MG, Barr IG. Laboratorydiagnosis of human seasonal and pandemic influenza virus infection. Med J Aust 2006; 185: S48-53.

  69. Burnet F. Influenza virus on the developing egg. I. Changes associated with the development of an egg-passage strain of virus. Br J Exp Pathol 1936; 17: 282-293.

  70. WHO. http://www.who.int/csr/disease/avian_influenza/ guidelines/RapidTestInfluenza_web.pdf.

  71. CDC. http://www.cdc.gov/flu/professionals/diagnosis/ rapidlab.htm.

  72. Brown TA, Murphy BR, Radl J, Haaijman JJ, Mestecky J. Subclass distribution and molecular form of immunoglobulin A hemagglutinin antibodies in sera and nasal secretions after experimental secondary infection with influenza A virus in humans. J Clin Microbiol 1985; 22: 259-264.

  73. Murphy BR, Clements ML. The systemic and mucosalimmune response of humans to influenza A virus. Curr Top Microbiol Immunol 1989; 146: 107-116.

  74. Iwane MK, Edwards KM, Szilagyi PG, Walker FJ, Griffin MR, Weinberg GA, et al. Populationbased surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children. Pediatrics 2004; 113: 1758-1764.

  75. Monto AS. Antivirals and influenza: frequency of resistance. Pediatr Infect Dis J 2008; 27: S110- 112.

  76. Varghese JN, Laver WG, Colman PM. Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 A resolution. Nature 1983; 303: 35-40.

  77. Hay AJ. The action of adamantanamines against influenza A viruses: inhibition of the M2 ion channel protein. Semin Virol 1992; 3: 21–30.

  78. Li KS, Guan Y, Wang J, Smith GJ, Xu KM, Duan L, et al. Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia. Nature 2004; 430: 209-213.

  79. Moscona A. Neuraminidase inhibitors for influenza. N Engl J Med 2005; 353: 1363-1373.

  80. Moscona A. Oseltamivir resistance--disabling our influenza defenses. N Engl J Med 2005; 353: 2633-2636.

  81. Hayden FG, Atmar RL, Schilling M, Johnson C, Poretz D, Paar D, et al. Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza. N Engl J Med 1999; 341: 1336-1343.

  82. Hayden FG, Treanor JJ, Betts RF, Lobo M, Esinhart JD, Hussey EK. Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza. Jama 1996; 275: 295-299.

  83. Harper SA, Fukuda K, Uyeki TM, Cox NJ, Bridges CB. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2005; 54: 1-40.

  84. Nichol KL. Efficacy and effectiveness of influenza vaccination. Vaccine 2008; 26 Suppl 4: D17-22.

  85. Nichol KL, Mendelman PM, Mallon KP, Jackson LA, Gorse GJ, Belshe RB, et al. Effectiveness oflive, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial. Jama 1999; 282: 137-144.

  86. Belshe RB, Mendelman PM, Treanor J, King J, Gruber WC, Piedra P, et al. The efficacy of liveattenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. N Engl J Med 1998; 338: 1405-1412.

  87. Belshe RB, Ambrose CS, Yi T. Safety and efficacy of live attenuated influenza vaccine in children 2-7 years of age. Vaccine 2008; 26 Suppl 4: D10-16.

  88. Boyce TG, Gruber WC, Coleman-Dockery SD, Sannella EC, Reed GW, Wolff M, et al. Mucosal immune response to trivalent live attenuated intranasal influenza vaccine in children. Vaccine 1999; 18: 82-88.

  89. Wright PF, Neumann G, Kawaoka Y. Orthomyxoviruses. In: Knipe DM, Howley PM, eds. Fields virology. 5th ed. Lippincott Williams & Wilkins. 2007: 1692-1740.

  90. New influenza A(H1N1) virus infections: global surveillance summary, May 2009. Wkly Epidemiol Rec 2009; 84: 173-179.

  91. Novel Swine-Origin Influenza A (H1N1) Virus in Humans. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Eng J Med 2009; 360: 1-16.




2020     |     www.medigraphic.com